NM_000238.4:c.1264G>A
Variant summary
Our verdict is Pathogenic. The variant received 19 ACMG points: 19P and 0B. PM1PM2PM5PP2PP3_StrongPP5_Very_Strong
The NM_000238.4(KCNH2):c.1264G>A(p.Ala422Thr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 13/23 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A422D) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000238.4 missense
Scores
Clinical Significance
Conservation
Publications
- long QT syndromeInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- long QT syndrome 2Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
- short QT syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
- short QT syndrome type 1Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
- Brugada syndromeInheritance: AD Classification: MODERATE, NO_KNOWN Submitted by: ClinGen, Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 19 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| KCNH2 | NM_000238.4 | c.1264G>A | p.Ala422Thr | missense_variant | Exon 6 of 15 | ENST00000262186.10 | NP_000229.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| KCNH2 | ENST00000262186.10 | c.1264G>A | p.Ala422Thr | missense_variant | Exon 6 of 15 | 1 | NM_000238.4 | ENSP00000262186.5 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 34
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:1
p.Ala422Thr (GCT>ACT):c.1264 G>A in exon 6 of the KCNH2 gene (NM_000238.2)The Ala422Thr mutation in the KCNH2 gene has been reported in association with LQTS (Tester D et al., 2005; Anderson C et al., 2006). Tester et al. identified Ala422Thr in one patient with LQTS and it was absent from 1,400 reference alleles tested. Functional studies performed report Ala422Thr utilizes a dominant mechanism leading to a loss of function of the ion channel (Anderson C et al., 2006). Ala422Thr results in a non-conservative amino acid substitution of a non-polar Alanine residue with a polar Threonine residue. Also, mutations in nearby codons (Tyr420Cys, Thr421Met, Pro426His, Tyr427Cys) have been reported in association with LQTS, further supporting the functional importance of this region of the protein.In summary, Ala422Thr in the KCNH2 gene is interpreted as a disease-causing mutation. The variant is found in LQT panel(s). -
Long QT syndrome Pathogenic:1
This sequence change replaces alanine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 422 of the KCNH2 protein (p.Ala422Thr). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with long QT Syndrome (PMID: 15242738, 15840476, 25254341). ClinVar contains an entry for this variant (Variation ID: 67174). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. Experimental studies have shown that this missense change affects KCNH2 function (PMID: 15242738, 16432067, 22580281, 23303164, 29904349, 31557540). This variant disrupts the p.Ala422 amino acid residue in KCNH2. Other variant(s) that disrupt this residue have been observed in individuals with KCNH2-related conditions (PMID: 28794082), which suggests that this may be a clinically significant amino acid residue. For these reasons, this variant has been classified as Pathogenic. -
Congenital long QT syndrome Other:1
This variant has been reported as associated with Long QT syndrome in the following publications (PMID:15242738;PMID:15840476;PMID:16432067;PMID:22580281). This is a literature report, and does not necessarily reflect the clinical interpretation of the Imperial College / Royal Brompton Cardiovascular Genetics laboratory. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at